Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Advancements in uterine sarcoma management : a review
Avtorji:ID Lebar, Vojka (Avtor)
ID Čelebić, Aleksandar (Avtor)
ID Calleja-Agius, Jean (Avtor)
ID Jakimovska, Marina (Avtor)
ID Drusany Starič, Kristina (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (501,02 KB)
MD5: 102C26614D75E86DECBE776C2DF6DBA9
 
URL URL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S0748798325000745?via%3Dihub
 
Jezik:Angleški jezik
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Uterine sarcomas are rare, accounting for 3–7% of uterine malignancies. This review aims to summarize advancements in diagnostics and treatment over the last decade, focusing on innovative imaging techniques, molecular diagnostics, and treatment modalities. Recent diagnostic advancements include enhanced imaging techniques such as MRI and AI-driven algorithms, improving accuracy in differentiating between benign and malignant uterine tumors. Biomarkers like lactate dehydrogenase (LDH) and microRNAs have shown potential in preoperative identification. Treatment strategies continue to evolve, with surgical resection being the cornerstone. The role of lymphadenectomy and adnexectomy varies by histopathological subtype, emphasizing personalized approaches. Adjuvant therapies remain controversial, tailored to patient risk factors and tumor characteristics. Fertility-sparing options are viable for selected patients, though not recommended for high-grade tumors. Significant progress in diagnostic techniques and personalized treatment approaches has improved the management of uterine sarcomas. Future guidelines from major oncology groups are expected to standardize care. Continued research is essential for refining treatment protocols and enhancing patient outcomes.
Ključne besede:uterine sarcomas, molecular diagnostics, artificial intelligence, treatment approache
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:str. 1-6
Številčenje:Vol. 51, iss. 4, [article no.] 109646
PID:20.500.12556/DiRROS-27719 Novo okno
UDK:616-006
ISSN pri članku:1532-2157
DOI:10.1016/j.ejso.2025.109646 Novo okno
COBISS.SI-ID:232012035 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 9. 4. 2025;
Datum objave v DiRROS:23.02.2026
Število ogledov:162
Število prenosov:71
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:European journal of surgical oncology
Skrajšan naslov:Eur. j. surg. oncol.
Založnik:Academic Press
ISSN:1532-2157
COBISS.SI-ID:59529475 Novo okno

Gradivo je financirano iz projekta

Financer:Drugi - Drug financer ali več financerjev
Program financ.:European Cooperation in Science and Technology
Številka projekta:CA 18117
Naslov:European Network for Gynaecological Rare Cancer Research: From Concept to Cure
Akronim:GYNOCARE

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.

Nazaj